Anebulo Pharmaceuticals, Inc. ANEB 深 滬
已收盤 02-06 16:00:00 美东时间
0.5005
-0.321
-39.05%
華盛通- 最 高0.66
- 今 開0.4401
- 成交量 79.32万股
- 最 低 0.4351
- 昨 收 0.8212
- 總市值 2041.28万
- 52周最高 3.42
- 市盈率 靜 --
- 換手率 1.94%
- 52周最低 0.4351
- 委 比 -32.95%
- 總股本 4078.47万
- 歷史最高 9.33
- 量 比 8.42
- 振 幅 27.39%
- 歷史最低 0.4351
- 每 手 1
- 風險率 0.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Anebulo Pharmaceuticals Voluntarily Delisting Common Shares From Nasdaq, Effective Feb. 27
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today
02-06 22:02
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Vyome Holdings (NASDAQ:HIND) stock increased by 16.1% to $2.23 during ...
02-02 20:05
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender
Anebulo Pharmaceuticals ( ($ANEB) ) has shared an announcement. On January 29, ...
01-29 23:03
Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million
Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million Anebulo Pharmaceuticals Inc. has announced the preliminary results of its voluntary self-tender offer, with the company expecting to purchase 300,000 shares of its common stock at a purchase price of $3.50 per share, for an aggregate
01-27 22:49
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results
Anebulo Pharmaceuticals ( ($ANEB) ) has shared an update. On January 27, 2026, ...
01-27 22:48
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
01-22 23:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SciSparc (NASDAQ:SPRC) shares rose 6.3% to $1.46 during Monday's after...
2025-12-30 05:05
How Is The Market Feeling About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
2025-12-27 01:00
Anebulo To Commence $3.50/Shr Cash Tender Offer For Up To 300K Shares As Part Of Plan To Go Private In Lieu Of Reverse Stock Split At Ratio Of Not Less Than 1-For-2,500 And Not Greater Than 1-For-7,500
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced
2025-12-22 22:05
Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses of $(0.08) per share
2025-11-14 05:33
